Cargando…
Six-year clinical outcomes of enzyme replacement therapy for perinatal lethal and infantile hypophosphatasia in Korea: Two case reports
Hypophosphatasia (HPP) is a genetic disease caused by loss-of-function mutations in ALPL, which encodes tissue-nonspecific alkaline phosphatase (ALP). Early diagnosis and treatment of perinatal and infantile HPP are important because of their high mortality rates. Enzyme replacement therapy (ERT) us...
Autores principales: | Kim, Insung, Noh, Eu-Seon, Kim, Min-Sun, Jang, Ja-Hyun, Jeon, Tae Yeon, Choi, Hae Won, Cho, Sung Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907957/ https://www.ncbi.nlm.nih.gov/pubmed/36820543 http://dx.doi.org/10.1097/MD.0000000000032800 |
Ejemplares similares
-
Radiologic placement of Hickman catheters using intravenous sedation in pediatric patients under 20 kg
por: Kim, Jin Hyeok, et al.
Publicado: (2022) -
Identification of FOXG1 mutations in infantile hypotonia and postnatal microcephaly
por: Jang, Han Na, et al.
Publicado: (2021) -
Transient infantile hypertriglyceridemia with jaundice: A case report
por: Wang, Jun, et al.
Publicado: (2021) -
Prenatal enzyme replacement therapy for Akp2(−/−) mice with lethal hypophosphatasia
por: Hasegawa, Akihiro, et al.
Publicado: (2021) -
Infantile-onset Pompe disease with neonatal debut: A case report and literature review
por: Martínez, Miriam, et al.
Publicado: (2017)